Continuum Advisory’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Continuum Advisory's DGX Position: Q2 2026 in Review
Continuum Advisory opened a new position in Quest Diagnostics (DGX) in Q2 2026: 611 shares worth $130K. The stake represents 0.01% of the portfolio and ranks #574 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in DGX as recently as Q1 2025.
Continuum Advisory first reported a position in DGX in Q1 2024 and has held it in 6 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Continuum Advisory held 611 shares of Quest Diagnostics worth $130K as of Q2 2026.
- Quest Diagnostics was a new Continuum Advisory position in Q2 2026.
- Quest Diagnostics made up 0.01% of Continuum Advisory's portfolio in Q2 2026, its #574 holding.
- Continuum Advisory first reported a position in Quest Diagnostics in Q1 2024 and has held it in 6 quarters since.
- 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.